Delivering reliable patient access, experienced investigators, and efficient trial execution in the heart of the Jacksonville Metro Area.
Delivering reliable patient access, experienced investigators, and efficient trial execution in the heart of the Green Leaf Clinical Trials.
Green Leaf Clinical Trials is a dedicated multi-specialty clinical research facility in Jacksonville, Florida, supporting a broad patient base with Phase II through Phase IV experience across a wide range of therapeutic areas.
Green Leaf Clinical Trials is part of ECN Clinical, a leading group of research sites dedicated to high-quality clinical trials across the United States.
Green Leaf Clinical Trials specializes in Internal Medicine and Family Medicine with deep experience across a range of complex conditions. Our investigators are selected for their therapeutic focus, ensuring every study benefits from genuine clinical expertise rather than generalist coverage.
Our patient recruitment infrastructure combines technology, community relationships, and dedicated outreach to deliver consistent enrollment performance across every study we support.
Green Leaf Clinical Trials serves a diverse adult and geriatric population ranging from 18 to over 80 years old, offering broad age-based inclusion for clinical trials. Our Jacksonville, Florida location gives us access to a vibrant, multicultural community with strong representation across Hispanic, White, African American, and Asian populations, making us an ideal site for studies with diversity enrollment requirements.
Jacksonville is one of Florida's most diverse cities, and Green Leaf Clinical Trials reflects that diversity across our active patient population. With 27% African-American and 18% Hispanic representation, our site helps sponsors meet FDA diversity requirements and build more inclusive development programs as part of the Clinical Research Site Network Jacksonville Florida.
Diversity in clinical research is more than a compliance requirement. It is a commitment to the communities we serve. Our sites are chosen and structured to reflect the communities they serve, ensuring every study benefits from genuine local representation, trust, and accessibility.
Download our network capability deck or TA-specific one-pagers to share with your team.
Green Leaf Clinical Trials has built a reputation as a trusted Jacksonville Center for Clinical Research through experienced investigators, high enrollment performance, and a participant experience built around flexibility and accessibility. Our CLIA-certified lab and Phase II through Phase IV capability make us a reliable partner for sponsors and CROs across a wide range of therapeutic areas.
Green Leaf Clinical Trials is one of Jacksonville's most experienced clinical trial research centers, located at 6100 Greenland Rd, Suite 702/905, Jacksonville, FL 32258. Serving a 40-mile catchment radius across Northeast Florida, our site is accessible to participants across the entire Jacksonville metropolitan area.
Key indicators of a strong clinical research facility include Phase II through Phase IV capability, a CLIA-certified laboratory, experienced principal investigators with subspecialty credentials, an active patient database, and proven startup timelines. Green Leaf Clinical Trials meets all of these benchmarks and operates within the ECN Clinical for added sponsor confidence.
Green Leaf Clinical Trials is an independent research site and a proud member of the ECN Clinical, one of the most trusted clinical research site networks in Jacksonville, Florida and across the United States. As part of this network, Green Leaf benefits from centralized contracting, unified SOPs, and network-level sponsor relationships while maintaining full accountability as a dedicated local site.
Green Leaf offers a fully equipped clinical research center with Phase II through Phase IV capability, a CLIA-certified lab with cold chain storage, onsite ECG and offsite imaging, CTMS and multiple EDC platforms, DEA-licensed drug storage, and specialty procedures including biopsies, infusion, PK sampling, spirometry, and certified FibroScan. Startup timelines average one day for CDA/NDA and five days for site activation.
